Shreyasi Chatterjee

996 total citations
13 papers, 694 citations indexed

About

Shreyasi Chatterjee is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Shreyasi Chatterjee has authored 13 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Shreyasi Chatterjee's work include Alzheimer's disease research and treatments (10 papers), Autophagy in Disease and Therapy (3 papers) and Cellular transport and secretion (3 papers). Shreyasi Chatterjee is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Autophagy in Disease and Therapy (3 papers) and Cellular transport and secretion (3 papers). Shreyasi Chatterjee collaborates with scholars based in United Kingdom, United States and Taiwan. Shreyasi Chatterjee's co-authors include Amritpal Mudher, George R. Jackson, Tzu‐Kang Sang, George Lawless, Surendra S. Ambegaokar, George R. Jackson, Bidisha Roy, Rakez Kayed, Mathieu F. Bakhoum and Urmi Sengupta and has published in prestigious journals such as Neuron, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Shreyasi Chatterjee

13 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shreyasi Chatterjee United Kingdom 9 364 265 156 127 118 13 694
Preeti J. Khandelwal United States 9 315 0.9× 263 1.0× 195 1.3× 137 1.1× 96 0.8× 12 688
Laura Barbiero Italy 12 381 1.0× 229 0.9× 108 0.7× 178 1.4× 89 0.8× 16 596
Xiaomin Yin China 15 398 1.1× 439 1.7× 57 0.4× 182 1.4× 111 0.9× 28 875
Natalia Salvadores Chile 13 485 1.3× 449 1.7× 141 0.9× 154 1.2× 50 0.4× 16 1.0k
Zhengwei Hu China 13 184 0.5× 320 1.2× 123 0.8× 105 0.8× 79 0.7× 37 642
Rita Cacace Belgium 10 402 1.1× 352 1.3× 113 0.7× 122 1.0× 85 0.7× 16 787
Sylvie Burnouf France 15 399 1.1× 213 0.8× 74 0.5× 263 2.1× 120 1.0× 19 728
Md Shahaduzzaman United States 10 204 0.6× 217 0.8× 165 1.1× 120 0.9× 58 0.5× 10 629
Katsue Miyoshi Japan 8 288 0.8× 188 0.7× 64 0.4× 92 0.7× 87 0.7× 11 484
Jérôme Braudeau France 10 328 0.9× 331 1.2× 36 0.2× 128 1.0× 72 0.6× 20 726

Countries citing papers authored by Shreyasi Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Shreyasi Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shreyasi Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shreyasi Chatterjee more than expected).

Fields of papers citing papers by Shreyasi Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shreyasi Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shreyasi Chatterjee. The network helps show where Shreyasi Chatterjee may publish in the future.

Co-authorship network of co-authors of Shreyasi Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Shreyasi Chatterjee. A scholar is included among the top collaborators of Shreyasi Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shreyasi Chatterjee. Shreyasi Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhang, Yongrui, Shreyasi Chatterjee, Nigel J. Fullwood, et al.. (2024). A novel peptide‐based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies. Alzheimer s & Dementia. 20(11). 7788–7804. 8 indexed citations
2.
Sang, Tzu‐Kang, et al.. (2023). Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD. Frontiers in Genetics. 14. 2 indexed citations
3.
Chatterjee, Shreyasi, Megan Sealey, Keeley J. Brookes, et al.. (2023). Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration. PLoS ONE. 18(1). e0262792–e0262792. 13 indexed citations
4.
5.
Chatterjee, Shreyasi, et al.. (2019). Insulin-Mediated Changes in Tau Hyperphosphorylation and Autophagy in a Drosophila Model of Tauopathy and Neuroblastoma Cells. Frontiers in Neuroscience. 13. 801–801. 23 indexed citations
6.
Kurbatskaya, Ksenia, et al.. (2018). Modelling neurodegenerative diseases <em>in vitro</em>: Recent advances in 3D iPSC technologies. ePrints Soton (University of Southampton). 2(1). 1–23. 8 indexed citations
7.
Chatterjee, Shreyasi & Amritpal Mudher. (2018). Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Frontiers in Neuroscience. 12. 383–383. 193 indexed citations
8.
Chouhan, Amit K., Caiwei Guo, Yi‐Chen Hsieh, et al.. (2016). Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease. Acta Neuropathologica Communications. 4(1). 62–62. 58 indexed citations
9.
Roy, Bidisha, Shreyasi Chatterjee, Mathieu F. Bakhoum, et al.. (2013). TDP-43 Phosphorylation by casein kinase Iε promotes oligomerization and enhances toxicity in vivo. Human Molecular Genetics. 23(4). 1025–1035. 87 indexed citations
10.
Chatterjee, Shreyasi, Tzu‐Kang Sang, George Lawless, & George R. Jackson. (2008). Dissociation of tau toxicity and phosphorylation: role of GSK-3β, MARK and Cdk5 in a Drosophila model. Human Molecular Genetics. 18(1). 164–177. 130 indexed citations
11.
Karsten, Stanislav L., Tzu‐Kang Sang, Lauren Gehman, et al.. (2006). A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration. Neuron. 51(5). 549–560. 112 indexed citations
12.
Chatterjee, Shreyasi, et al.. (2000). A high yielding mutant of mycobacteriophage L1 and its application as a diagnostic tool. FEMS Microbiology Letters. 188(1). 47–53. 16 indexed citations
13.
Goulding, J. M. R., D. F. Signorini, Shreyasi Chatterjee, et al.. (1999). Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. Journal of Neurology Neurosurgery & Psychiatry. 67(5). 654–657. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Preeti J. Khandelwal Breakdown of academic impact, for papers by Laura Barbiero Breakdown of academic impact, for papers by Xiaomin Yin Breakdown of academic impact, for papers by Natalia Salvadores Breakdown of academic impact, for papers by Zhengwei Hu Breakdown of academic impact, for papers by Rita Cacace Breakdown of academic impact, for papers by Sylvie Burnouf Breakdown of academic impact, for papers by Md Shahaduzzaman Breakdown of academic impact, for papers by Katsue Miyoshi Breakdown of academic impact, for papers by Jérôme Braudeau
Rankless by CCL
2026